Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/173437
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Machlab, Salvador | - |
dc.contributor.author | Martínez-Bauer, Eva | - |
dc.contributor.author | López, Pilar | - |
dc.contributor.author | Piqué i Clusella, Núria | - |
dc.contributor.author | Puig-Diví, Valentí | - |
dc.contributor.author | Junquera, Félix | - |
dc.contributor.author | Lira, Alba | - |
dc.contributor.author | Brullet, Enric | - |
dc.contributor.author | Selva, Anna | - |
dc.contributor.author | García-Iglesias, Pilar | - |
dc.contributor.author | Calvet, Xavier | - |
dc.contributor.author | Campo Fernández de los Rios, Rafael | - |
dc.date.accessioned | 2021-01-28T06:49:48Z | - |
dc.date.available | 2021-10-05T05:10:13Z | - |
dc.date.issued | 2020-10-05 | - |
dc.identifier.issn | 0915-5635 | - |
dc.identifier.uri | https://hdl.handle.net/2445/173437 | - |
dc.description.abstract | Background and aims: There is controversy about the length of low-residue diet (LRD) for colonoscopy preparation. The aim of the study was to compare one-day vs. three-day LRD associated to standard laxative treatment for achieving an adequate colonoscopy preparation in average risk subjects with positive fecal immunochemical test undergoing screening colonoscopy. Methods: A non-inferiority, randomized, controlled, parallel-group clinical trial was performed in the setting of average risk colorectal cancer screening program. Participants were randomized to receive 1-day vs. 3-day LRD in addition to standard polyethilenglicol treatment. Adequacy of preparation was evaluated using the Boston Bowel Preparation Scale (BBPS). Primary outcome was achieving a BBPS ≥ 2 in all colon segments. Analysis was performed for a non-inferiority margin of 5%, a 95% statistical power and one-sided 0.05 significance level. Results: A total of 855 patients were randomized. Adequate bowel preparation was similar between groups: 97.9% of patients in the 1-day LRD group vs 96.9% in the 3-day LRD group achieved the primary outcome (P-value for non-inferiority < 0.001). The percentage of patients with BBPS scores ≥ 8 was superior in the 1-day LRD group (254 vs 221 in the 3-day LRD group, P = 0.032). The 1-day regimen was better tolerated than the 3-day diet. 47.7% (vs 28.7%, P < 0.05) of patients rated the 1-day LRD as very easy to follow. Conclusion: The 1-day LRD is non-inferior to 3-day LRD for achieving an adequate colon cleansing before average risk screening colonoscopy and it is better tolerated. Keywords: bowel preparation; colonoscopy; colorectal cancer; screening. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Wiley | - |
dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1111/den.13860 | - |
dc.relation.ispartof | Digestive Endoscopy, 2020 | - |
dc.relation.uri | https://doi.org/10.1111/den.13860 | - |
dc.rights | (c) Japan Gastroenterological Endoscopy Society, 2020 | - |
dc.source | Articles publicats en revistes (Biologia, Sanitat i Medi Ambient) | - |
dc.subject.classification | Càncer colorectal | - |
dc.subject.classification | Colonoscòpia | - |
dc.subject.classification | Dieta | - |
dc.subject.other | Colorectal cancer | - |
dc.subject.other | Colonoscopy | - |
dc.subject.other | Diet | - |
dc.title | Comparable quality of bowel preparation with single‐day versus three‐day low‐residue diet: Randomized controlled trial | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/acceptedVersion | - |
dc.identifier.idgrec | 705581 | - |
dc.date.updated | 2021-01-28T06:49:48Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Biologia, Sanitat i Medi Ambient) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
705581.pdf | 2.46 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.